Cargando…

Temporal trends in clinical characteristics and in-hospital mortality among patients with COVID-19 in Japan for waves 1, 2, and 3: A retrospective cohort study

INTRODUCTION: Little information is available on the temporal trends in the clinical epidemiology and in-hospital mortality of patients with coronavirus disease 2019 (COVID-19) in Japan for waves 1, 2, and 3. METHODS: A national claims database was used to analyze the time trends in admission, medic...

Descripción completa

Detalles Bibliográficos
Autores principales: Endo, Hideki, Lee, Kyunghee, Ohnuma, Tetsu, Watanabe, Senri, Fushimi, Kiyohide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239980/
https://www.ncbi.nlm.nih.gov/pubmed/35779801
http://dx.doi.org/10.1016/j.jiac.2022.06.013
_version_ 1784737435479965696
author Endo, Hideki
Lee, Kyunghee
Ohnuma, Tetsu
Watanabe, Senri
Fushimi, Kiyohide
author_facet Endo, Hideki
Lee, Kyunghee
Ohnuma, Tetsu
Watanabe, Senri
Fushimi, Kiyohide
author_sort Endo, Hideki
collection PubMed
description INTRODUCTION: Little information is available on the temporal trends in the clinical epidemiology and in-hospital mortality of patients with coronavirus disease 2019 (COVID-19) in Japan for waves 1, 2, and 3. METHODS: A national claims database was used to analyze the time trends in admission, medical procedure, and in-hospital mortality characteristics among patients with COVID-19. Patients who were ≥18 years and discharged from January 1, 2020 to February 28, 2021 were included. RESULTS: A multilevel logistic regression analysis of 51,252 patients revealed a decline in mortality in waves 2 and 3 (risk-adjusted mortality range = 2.17–4.07%; relative risk reduction = 23–59%; reference month of April 2020 = 5.32%). In the subgroup analysis, a decline in mortality was also observed in patients requiring oxygen support but not mechanical ventilation (risk-adjusted mortality range = 5.98–11.68%; relative risk reduction = 22–60%; reference month of April 2020 = 15.06%). Further adjustments for medical procedure changes in the entire study population revealed a decrease in mortality in waves 2 and 3 (risk-adjusted mortality range = 2.66–4.05%; relative risk reduction = 24–50%). CONCLUSIONS: A decline in in-hospital mortality was observed in waves 2 and 3 after adjusting for patient/hospital-level characteristics and medical treatments. The reasons for this decline warrant further research to improve the outcomes of hospitalized patients.
format Online
Article
Text
id pubmed-9239980
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-92399802022-06-29 Temporal trends in clinical characteristics and in-hospital mortality among patients with COVID-19 in Japan for waves 1, 2, and 3: A retrospective cohort study Endo, Hideki Lee, Kyunghee Ohnuma, Tetsu Watanabe, Senri Fushimi, Kiyohide J Infect Chemother Original Article INTRODUCTION: Little information is available on the temporal trends in the clinical epidemiology and in-hospital mortality of patients with coronavirus disease 2019 (COVID-19) in Japan for waves 1, 2, and 3. METHODS: A national claims database was used to analyze the time trends in admission, medical procedure, and in-hospital mortality characteristics among patients with COVID-19. Patients who were ≥18 years and discharged from January 1, 2020 to February 28, 2021 were included. RESULTS: A multilevel logistic regression analysis of 51,252 patients revealed a decline in mortality in waves 2 and 3 (risk-adjusted mortality range = 2.17–4.07%; relative risk reduction = 23–59%; reference month of April 2020 = 5.32%). In the subgroup analysis, a decline in mortality was also observed in patients requiring oxygen support but not mechanical ventilation (risk-adjusted mortality range = 5.98–11.68%; relative risk reduction = 22–60%; reference month of April 2020 = 15.06%). Further adjustments for medical procedure changes in the entire study population revealed a decrease in mortality in waves 2 and 3 (risk-adjusted mortality range = 2.66–4.05%; relative risk reduction = 24–50%). CONCLUSIONS: A decline in in-hospital mortality was observed in waves 2 and 3 after adjusting for patient/hospital-level characteristics and medical treatments. The reasons for this decline warrant further research to improve the outcomes of hospitalized patients. Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. 2022-10 2022-06-29 /pmc/articles/PMC9239980/ /pubmed/35779801 http://dx.doi.org/10.1016/j.jiac.2022.06.013 Text en © 2022 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Original Article
Endo, Hideki
Lee, Kyunghee
Ohnuma, Tetsu
Watanabe, Senri
Fushimi, Kiyohide
Temporal trends in clinical characteristics and in-hospital mortality among patients with COVID-19 in Japan for waves 1, 2, and 3: A retrospective cohort study
title Temporal trends in clinical characteristics and in-hospital mortality among patients with COVID-19 in Japan for waves 1, 2, and 3: A retrospective cohort study
title_full Temporal trends in clinical characteristics and in-hospital mortality among patients with COVID-19 in Japan for waves 1, 2, and 3: A retrospective cohort study
title_fullStr Temporal trends in clinical characteristics and in-hospital mortality among patients with COVID-19 in Japan for waves 1, 2, and 3: A retrospective cohort study
title_full_unstemmed Temporal trends in clinical characteristics and in-hospital mortality among patients with COVID-19 in Japan for waves 1, 2, and 3: A retrospective cohort study
title_short Temporal trends in clinical characteristics and in-hospital mortality among patients with COVID-19 in Japan for waves 1, 2, and 3: A retrospective cohort study
title_sort temporal trends in clinical characteristics and in-hospital mortality among patients with covid-19 in japan for waves 1, 2, and 3: a retrospective cohort study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239980/
https://www.ncbi.nlm.nih.gov/pubmed/35779801
http://dx.doi.org/10.1016/j.jiac.2022.06.013
work_keys_str_mv AT endohideki temporaltrendsinclinicalcharacteristicsandinhospitalmortalityamongpatientswithcovid19injapanforwaves12and3aretrospectivecohortstudy
AT leekyunghee temporaltrendsinclinicalcharacteristicsandinhospitalmortalityamongpatientswithcovid19injapanforwaves12and3aretrospectivecohortstudy
AT ohnumatetsu temporaltrendsinclinicalcharacteristicsandinhospitalmortalityamongpatientswithcovid19injapanforwaves12and3aretrospectivecohortstudy
AT watanabesenri temporaltrendsinclinicalcharacteristicsandinhospitalmortalityamongpatientswithcovid19injapanforwaves12and3aretrospectivecohortstudy
AT fushimikiyohide temporaltrendsinclinicalcharacteristicsandinhospitalmortalityamongpatientswithcovid19injapanforwaves12and3aretrospectivecohortstudy